BMS-935177
HY-101793 25mg
EUR 877

BMS-986142
HY-101856 10mM/1mL
EUR 845

BMS-309403
HY-101903 25mg
EUR 279

BMS-754807
HY-10200 100mg
EUR 946

BMS-1166
HY-102011 25mg
EUR 2058

BMS-599626
HY-10251 50mg
EUR 670

BMS-536924
HY-10262 10mM/1mL
EUR 156

BMS-690514
HY-10333 2mg
EUR 271

BMS-794833
HY-10497 50mg
EUR 980

BMS-345541
HY-10519 50mg
EUR 932

BMS-687453
HY-10678 100mg
EUR 1359

BMS-191011
HY-108593 100mg
EUR 785

BMS-813160
HY-109593 100mg
EUR 2288

BMS-509744
HY-11092 5mg
EUR 229

BMS-986165
HY-117287 50mg
EUR 3206

BMS-193885
HY-120619 10mg
EUR 509

BMS 777607
HY-12076 50mg
EUR 533

BMS-564929
HY-12111 10mM/1mL
EUR 216

BMS-983970
HY-12419 5mg
EUR 533

BMS-819881
HY-12433 10mg
EUR 3913

BMS-707035
HY-13269 10mM/1mL
EUR 156

BMS-833923
HY-13809 100mg
EUR 573

BMS-378806
HY-14134 50mg
EUR 1187

BMS-191095
HY-14256 50mg
EUR 2254

BMS-911543
HY-15270 10mM/1mL
EUR 195

BMS-265246
HY-15275 100mg
EUR 1949

BMS-303141
HY-16107 10mM/1mL
EUR 148

BMS-214662
HY-16111 1mg
EUR 257

BMS-3
HY-18304 10mM/1mL
EUR 186

BMS-5
HY-18305 100mg
EUR 911

BMS-202
HY-19745 100mg
EUR 1359

BMS-779788
HY-19919 2mg
EUR 108

BMS-1
HY-19991 10mM/1mL
EUR 231

BMS 299897
HY-50883 50mg
EUR 429

BMS 433796
HY-50884 5mg
EUR 2254

Bms 626529
20-abx182383
  • EUR 1720.00
  • EUR 620.00
  • 100 mg
  • 10 mg

BMS-754807
A1185-25 25 mg
EUR 340
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies.

BMS-754807
A1185-5 5 mg
EUR 125
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies.

BMS-754807
A1185-5.1 10 mM (in 1mL DMSO)
EUR 154
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies.

BMS-536924
A2238-10 10 mg
EUR 247
Description: BMS-536924 is a novel inhibitor of IGF-1R with IC50 value of 100nM [1].It has been found that BMS-536924 has cell toxicity in OVCAR-3 and OVCAR-4 cell lines.

BMS-536924
A2238-5 5 mg
EUR 166
Description: BMS-536924 is a novel inhibitor of IGF-1R with IC50 value of 100nM [1].It has been found that BMS-536924 has cell toxicity in OVCAR-3 and OVCAR-4 cell lines.

BMS-536924
A2238-5.1 10 mM (in 1mL DMSO)
EUR 258
Description: BMS-536924 is a novel inhibitor of IGF-1R with IC50 value of 100nM [1].It has been found that BMS-536924 has cell toxicity in OVCAR-3 and OVCAR-4 cell lines.

BMS-536924
A2238-50 50 mg
EUR 920
Description: BMS-536924 is a novel inhibitor of IGF-1R with IC50 value of 100nM [1].It has been found that BMS-536924 has cell toxicity in OVCAR-3 and OVCAR-4 cell lines.

BMS-509744
A3250-10 10 mg
EUR 412
Description: BMS-509744 is a selective inhibitor of ITK with IC50 value of 15 nM [1].ITK (IL-2-inducible T cell kinase) is an enzyme and plays an important role in T cell receptor signaling.

BMS-509744
A3250-5 5 mg
EUR 284
Description: BMS-509744 is a selective inhibitor of ITK with IC50 value of 15 nM [1].ITK (IL-2-inducible T cell kinase) is an enzyme and plays an important role in T cell receptor signaling.

BMS-509744
A3250-50 50 mg
EUR 1678
Description: BMS-509744 is a selective inhibitor of ITK with IC50 value of 15 nM [1].ITK (IL-2-inducible T cell kinase) is an enzyme and plays an important role in T cell receptor signaling.

BMS-626529
A3253-10 10 mg
EUR 340
Description: EC50HIV-1 attachment inhibitors represent a new class of entry inhibitors that prevent the initial interaction between virus and host cell by binding to the viral envelope protein gp120 and blocking attachment of the virus to the CD4 receptor on CD4+ T-cells.

BMS-626529
A3253-200 200 mg
EUR 1790
Description: EC50HIV-1 attachment inhibitors represent a new class of entry inhibitors that prevent the initial interaction between virus and host cell by binding to the viral envelope protein gp120 and blocking attachment of the virus to the CD4 receptor on CD4+ T-cells.

BMS-626529
A3253-5 5 mg
EUR 224
Description: EC50HIV-1 attachment inhibitors represent a new class of entry inhibitors that prevent the initial interaction between virus and host cell by binding to the viral envelope protein gp120 and blocking attachment of the virus to the CD4 receptor on CD4+ T-cells.

BMS-626529
A3253-50 50 mg
EUR 920
Description: EC50HIV-1 attachment inhibitors represent a new class of entry inhibitors that prevent the initial interaction between virus and host cell by binding to the viral envelope protein gp120 and blocking attachment of the virus to the CD4 receptor on CD4+ T-cells.

BMS-663068
A3254-5 5 mg
EUR 300
Description: BMS-663068 is a small-molecule attachment inhibitor of HIV-1 gp120 with IC50 value of [1].The first step of HIV-1 virus to entry host cells is the binding of the viral gp120 envelope glycopeptide to the CD4 receptor of host cell.

BMS-663068
A3254-5.1 10 mM (in 1mL DMSO)
EUR 398
Description: BMS-663068 is a small-molecule attachment inhibitor of HIV-1 gp120 with IC50 value of [1].The first step of HIV-1 virus to entry host cells is the binding of the viral gp120 envelope glycopeptide to the CD4 receptor of host cell.

BMS-690514
A3256-10 10 mg
EUR 693
Description: BMS-690514, a potent inhibitor of human epidermal growth factor receptor (HER/EGFR).

BMS-690514
A3256-5 5 mg
EUR 450
Description: BMS-690514, a potent inhibitor of human epidermal growth factor receptor (HER/EGFR).

BMS-690514
A3256-5.1 10 mM (in 1mL DMSO)
EUR 400
Description: BMS-690514, a potent inhibitor of human epidermal growth factor receptor (HER/EGFR).

BMS-690514
A3256-50 50 mg
EUR 1703
Description: BMS-690514, a potent inhibitor of human epidermal growth factor receptor (HER/EGFR).

BMS-833923
A3258-10 10 mg
EUR 131
Description: BMS-833923 is an orally bioavailable and selective antagonist of smoothened (SMO) with IC50 value of 5.8 nM in NIH3T3 cell line [1].The Hedgehog (Hh) signaling is a critical pathway involved in embryonic development and in tissue maintenance and repair in adults.

BMS-833923
A3258-5 5 mg
EUR 102
Description: BMS-833923 is an orally bioavailable and selective antagonist of smoothened (SMO) with IC50 value of 5.8 nM in NIH3T3 cell line [1].The Hedgehog (Hh) signaling is a critical pathway involved in embryonic development and in tissue maintenance and repair in adults.

BMS-833923
A3258-5.1 10 mM (in 1mL DMSO)
EUR 167
Description: BMS-833923 is an orally bioavailable and selective antagonist of smoothened (SMO) with IC50 value of 5.8 nM in NIH3T3 cell line [1].The Hedgehog (Hh) signaling is a critical pathway involved in embryonic development and in tissue maintenance and repair in adults.

BMS-833923
A3258-50 50 mg
EUR 282
Description: BMS-833923 is an orally bioavailable and selective antagonist of smoothened (SMO) with IC50 value of 5.8 nM in NIH3T3 cell line [1].The Hedgehog (Hh) signaling is a critical pathway involved in embryonic development and in tissue maintenance and repair in adults.

BMS-927711
A3259-10 10 mg
EUR 628
Description: BMS-927711 is an orally potent CGRP receptor antagonist with IC50 of 0.14 nM. [1]Calcitonin gene-related peptide CGRP is a 37 amino acid peptide widely distributed in the nervous system, which is a highly potent vasodilator that has been directly implicated in the pathology of migraine.

BMS-927711
A3259-100 100 mg
EUR 3850
Description: BMS-927711 is an orally potent CGRP receptor antagonist with IC50 of 0.14 nM. [1]Calcitonin gene-related peptide CGRP is a 37 amino acid peptide widely distributed in the nervous system, which is a highly potent vasodilator that has been directly implicated in the pathology of migraine.

BMS-927711
A3259-5 5 mg
EUR 376
Description: BMS-927711 is an orally potent CGRP receptor antagonist with IC50 of 0.14 nM. [1]Calcitonin gene-related peptide CGRP is a 37 amino acid peptide widely distributed in the nervous system, which is a highly potent vasodilator that has been directly implicated in the pathology of migraine.

BMS-927711
A3259-50 50 mg
EUR 2222
Description: BMS-927711 is an orally potent CGRP receptor antagonist with IC50 of 0.14 nM. [1]Calcitonin gene-related peptide CGRP is a 37 amino acid peptide widely distributed in the nervous system, which is a highly potent vasodilator that has been directly implicated in the pathology of migraine.

BMS-794833
B1438-10 10 mg
EUR 253
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-794833
B1438-5 5 mg
EUR 164
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-794833
B1438-5.1 10 mM (in 1mL DMSO)
EUR 177
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-794833
B1438-50 50 mg
EUR 833
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-794833
B1438-S Evaluation Sample
EUR 81
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days.

BMS-378806
B1533-10 10 mg
EUR 305
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-378806
B1533-100 100 mg
EUR 1186
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-378806
B1533-5.1 10 mM (in 1mL DMSO)
EUR 235
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS-378806
B1533-50 50 mg
EUR 838
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM.

BMS 753
B5438-10 10 mg
EUR 350
Description: Ki : 2 nM for RAR? Three retinoic acid receptors (RAR?, RAR? and RAR? and three retinoid X receptors, members of the nuclear receptor (NR) superfamily, mediate the biological effects of retinoic acids upon development, cell differentiation and proliferation, and homeostasis.

BMS 753
B5438-50 50 mg
EUR 1266
Description: Ki : 2 nM for RAR? Three retinoic acid receptors (RAR?, RAR? and RAR? and three retinoid X receptors, members of the nuclear receptor (NR) superfamily, mediate the biological effects of retinoic acids upon development, cell differentiation and proliferation, and homeostasis.

BMS-817378
B5862-10 10 mg
EUR 311
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility.

BMS-817378
B5862-5 5 mg
EUR 189
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility.

BMS-817378
B5862-50 50 mg
EUR 833
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility.

BMS-582949
B6187-1 1 mg
EUR 145
Description: IC50: 13 nMBMS-582949 is a p38 MAPK inhibitorp38R MAP kinase plays a key role in regulating the biosynthesis of various inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-1?.

BMS-582949
B6187-25 25 mg
EUR 777
Description: IC50: 13 nMBMS-582949 is a p38 MAPK inhibitorp38R MAP kinase plays a key role in regulating the biosynthesis of various inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-1?.

BMS-582949
B6187-5 5 mg
EUR 290
Description: IC50: 13 nMBMS-582949 is a p38 MAPK inhibitorp38R MAP kinase plays a key role in regulating the biosynthesis of various inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-1?.

BMS-707035
A4069-10 10 mg
EUR 195
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell.

BMS-707035
A4069-100 100 mg
EUR 885
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell.

BMS-707035
A4069-5 5 mg
EUR 131
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell.

BMS-707035
A4069-50 50 mg
EUR 560
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell.

BMS-911543
A4152-10 10 mg
EUR 400
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity.

BMS-911543
A4152-25 25 mg
EUR 595
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity.

BMS-911543
A4152-5 5 mg
EUR 244
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity.

BMS-911543
A4152-50 50 mg
EUR 827
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity.

BMS 299897
A4400-10 10 mg
EUR 277
Description: BMS-299897 is a selective inhibitor of ?-secretase with IC50 value of 12 nM [1]. ?-secretase is an intergral membrane protein whose well-known substrate is amyloid precursor protein and involves in the process of cleaving single-pass transmembrane proteins at residues with the transmembrane domain.